Publications by authors named "Barbara-Alex Alberts"
Article Synopsis
- - Oral semaglutide was shown to improve cardiovascular risk factors in type 2 diabetes patients in a real-world setting, as evidenced by significant reductions in weight, blood pressure, and cholesterol levels over time.
- - A study involving 76 patients highlighted that the primary reasons for starting the medication were weight loss and improved blood sugar control, with positive results observed within 3-6 months and sustained improvements at the 6-12 month mark.
- - While 23.6% of patients discontinued the drug mainly due to gastrointestinal issues, there were no serious adverse events noted, supporting the medication's overall safety and effectiveness in this population.
